145
Views
14
CrossRef citations to date
0
Altmetric
Original

Treatment Entry among Individuals on a Waiting List for Methadone Maintenance

, M.A., , M.D., , Ph.D. & , M.D.
Pages 290-294 | Published online: 15 Sep 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Gerdien H. de Weert-van Oene, Vanesa Gongora, Kirk von Sternberg & Cor A. J. de Jong. (2015) Motivation for Treatment and Motivation for Change in Substance-Dependent Patients with Co-Occurring Psychiatric Disorders. Journal of Psychoactive Drugs 47:5, pages 393-400.
Read now
Christina M. Andrews, Hee-Choon Shin, Jeanne C. Marsh & Dingcai Cao. (2013) Client and Program Characteristics Associated with Wait Time to Substance Abuse Treatment Entry. The American Journal of Drug and Alcohol Abuse 39:1, pages 61-68.
Read now
Jan Gryczynski, Robert Schwartz, Kevin O'Grady & Jerome Jaffe. (2009) Dropout from Interim Methadone and Subsequent Comprehensive Methadone Maintenance. The American Journal of Drug and Alcohol Abuse 35:6, pages 394-398.
Read now

Articles from other publishers (11)

Noa Krawczyk, Paul J Joudrey, Rachel Simon, Danielle M Russel & David Frank. (2023) Recent modifications to the US methadone treatment system are a Band-Aid—not a solution—to the nation's broken opioid use disorder treatment system. Health Affairs Scholar 1:1.
Crossref
Tatum N. Oleskowicz, Taylor A. Ochalek, Kelly R. Peck, Gary J. Badger & Stacey C. Sigmon. (2021) Within-subject evaluation of interim buprenorphine treatment during waitlist delays. Drug and Alcohol Dependence 220, pages 108532.
Crossref
Erin L. Winstanley. (2020) The Bell Tolls for Thee & Thine: Compassion Fatigue & the Overdose Epidemic. International Journal of Drug Policy 85, pages 102796.
Crossref
Lynn M. Madden, Scott O. Farnum, Kathryn F. Eggert, Andrew R. Quanbeck, Robert M. Freeman, Samuel A. Ball, Richard S. Schottenfeld, Julia M. Shi, Mary Ellen Savage & Declan T. Barry. (2018) An investigation of an open‐access model for scaling up methadone maintenance treatment. Addiction 113:8, pages 1450-1458.
Crossref
Stacey C. Sigmon, Andrew C. Meyer, Bryce Hruska, Taylor Ochalek, Gail Rose, Gary J. Badger, John R. Brooklyn, Sarah H. Heil, Stephen T. Higgins, Brent A. Moore & Robert P. Schwartz. (2015) Bridging waitlist delays with interim buprenorphine treatment: Initial feasibility. Addictive Behaviors 51, pages 136-142.
Crossref
Stacey C. Sigmon. (2015) Interim treatment: Bridging delays to opioid treatment access. Preventive Medicine 80, pages 32-36.
Crossref
Maayan Lawental. (2015) Effectiveness of Rapid Intake into Methadone Treatment: A Natural Experiment in Israel. European Addiction Research 21:4, pages 211-216.
Crossref
Jan Gryczynski, Jerome H. Jaffe, Robert P. Schwartz, Kristi A. Dušek, Nishan Gugsa, Cristin L. Monroe, Kevin E. O'Grady, Yngvild K. Olsen & Shannon Gwin Mitchell. (2013) Patient Perspectives on Choosing Buprenorphine Over Methadone in an Urban, Equal‐Access System. The American Journal on Addictions 22:3, pages 285-291.
Crossref
Lynn E. Taylor, Michaela A. Maynard, Peter D. Friedmann, Cynthia J. MacLeod, Josiah D. Rich, Timothy P. Flanigan & Diana L. Sylvestre. (2012) Buprenorphine for Human Immunodeficiency Virus/Hepatitis C Virus–coinfected Patients. Journal of Addiction Medicine 6:3, pages 179-185.
Crossref
Andrew R. Quanbeck, Lynn Madden, Eldon Edmundson, James H. FordIIII, K. John McConnell, Dennis McCarty & David H. Gustafson. (2011) A Business Case for Quality Improvement in Addiction Treatment: Evidence from the NIATx Collaborative. The Journal of Behavioral Health Services & Research 39:1, pages 91-100.
Crossref
Jan Gryczynski, Robert P. Schwartz, David S. Salkever, Shannon Gwin Mitchell & Jerome H. Jaffe. (2011) Patterns in admission delays to outpatient methadone treatment in the United States. Journal of Substance Abuse Treatment 41:4, pages 431-439.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.